Summary of Key Information:

Nature of Filing / Announcement: Outcome of Board Meeting under Regulation 30 & 51 of SEBI Listing Regulations

Date of Board Meeting / Approval: Monday, August 10, 2026

Meeting Time: Commenced at 03:30 p.m. (IST) and concluded at 03:45 p.m. (IST)

Corporate Actions:

The Board of Directors approved:

  • The appointment of Mr. Anish Vanraj Bafna (DIN: 02925792) as an Additional Director, designated as a Non-Executive Independent Director of the Company, with effect from August 10, 2026.
  • The appointment was based on the recommendation of the Nomination and Remuneration Committee.
  • A Postal Ballot Notice will be circulated to seek member approval for Mr. Bafna's appointment for a term of 5 (five) consecutive years.

Director Profile:

Name: Mr. Anish Vanraj Bafna (DIN: 02925792)

Experience:

  • Over 30 years of experience in the healthcare and medical devices sector
  • Significant experience in managing global healthcare businesses and operations across multiple geographies
  • Previously served as Chief Executive Officer and Managing Director of Healthium Medtech Limited ("Healthium") for over eight years
  • Currently serving as Non-Executive Chairman of Healthium
  • Prior roles include President – Japan at Baxter International and Regional Head – Emerging Asia at Baxter International, Singapore
  • Worked across Vietnam, Indonesia, Malaysia, Singapore, Japan and India

Education:

  • Bachelor's Degree in Science (Chemistry) from St. Xavier's, Ahmedabad
  • Post Graduate Diploma in Management (PGDM) from IMDR, Pune

Key Financial Highlights:

Not Specified

Standalone Results:

Not Specified

Consolidated Results:

Not Specified

Segment-wise Performance:

Not Specified

Other Significant Information:

Not Specified